Clinical trial
The Phase II Clinical Trials of Thalidomide in NTDT
NCT02995707 is registered in ClinicalTrials.gov with Xiao-Lin Yin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Phase II Clinical Trials of Thalidomide in NTDT
- Lead sponsor
- Xiao-Lin Yin
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2016
- Completion date
- March 31, 2018
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.